CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31 enrolled
Drug / intervention
NeuroStar TMSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02640950
NCT02640950N/ACompleted
CompareCT.gov

An Open Label Trial of TMS Therapy for Bipolar Depression

Sheppard Pratt Health System·interventional·Posted Dec 29, 2015·Updated Jun 1, 2022

In Brief

A clinical study evaluating NeuroStar TMS for Bipolar Depression. Completed, enrolled 31 participants across 2 sites.

Detailed Summary

Transcranial Magnetic Stimulation (TMS) is an increasingly accepted neurostimulation- based treatment for major depressive disorder. While there is a growing anecdotal database supporting its use in bipolar depression the investigators propose to collect open label efficacy and safety data in a small population of patients with clinically verified bipolar disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Depression
CountriesUnited States
CollaboratorsMayo Clinic

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 29, 2015
Enrollment StartDec 1, 2015
Primary CompletionJul 1, 2020
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 10.5 years ago

Interventions

NeuroStar TMSdevice

Transcranial Magnetic Stimulation